Skip to content
healthcare.dev

Acyclovir

NDC 70518-2117, Acyclovir, tablet, from REMEDYREPACK INC..

Product NDC
70518-2117
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203834
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACYCLOVIR400 mg/1

Pharmacologic classes

DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
70518-2117-07051821170030 TABLET in 1 BOTTLE, PLASTIC (70518-2117-0)
70518-2117-27051821170230 TABLET in 1 BLISTER PACK (70518-2117-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/38547daa-7d2f-4a7b-84d3-6e164984f958

Use it

Look up 70518-2117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-2117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.